Elicio Therapeutics appoints Preetam Shah as chief strategy, financial officer
PremiumThe FlyElicio Therapeutics appoints Preetam Shah as chief strategy, financial officer
12d ago
Elicio Therapeutics prices 1.26M shares at $7.925 in registered direct offering
Premium
The Fly
Elicio Therapeutics prices 1.26M shares at $7.925 in registered direct offering
2M ago
Elicio Therapeutics Advances with New Clinical Updates
Premium
Company Announcements
Elicio Therapeutics Advances with New Clinical Updates
2M ago
Elicio Therapeutics reports Q3 EPS ($1.39), consensus (73c)
PremiumThe FlyElicio Therapeutics reports Q3 EPS ($1.39), consensus (73c)
5M ago
Elicio Therapeutics files to sell 3.44M shares of common stock for holders
Premium
The Fly
Elicio Therapeutics files to sell 3.44M shares of common stock for holders
5M ago
Elicio Therapeutics presents updated preliminary results from AMPLIFY-7P
Premium
The Fly
Elicio Therapeutics presents updated preliminary results from AMPLIFY-7P
5M ago
KalVista names Brian Piekos as CFO
PremiumThe FlyKalVista names Brian Piekos as CFO
7M ago
Elicio Therapeutics CFO Brian Piekos Resigns Amicably
Premium
Company Announcements
Elicio Therapeutics CFO Brian Piekos Resigns Amicably
7M ago
Is ELTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is ELTX a Buy, Before Earnings?
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100